Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
newt how you liking UNVC think were ready for a pop here?
gotta like the MM tricks today
$0.0011 -100,000 OTO 13:38:46 (110) last attempt before close to get the bid down aww no luck. LOL
$0.0011 -5,000 OTO 12:56:01 (5.50) LOL
$0.0011 -15,000 OTO 10:19:25 (16.50) LOL
lowman
go for it
David Dalton: 443-253-0194
Mods - is it really necessary having press releases in the ibox from 2002-2005 those days have come and gone. That's like saying looking what WaMu accomplished then and look at it now! Would prob make sense to pull it.
We need an update Dalton.
Jgygli,
I must say that is some map lol, where in heavens did you get that? I think it's great our CEO Dr. David Dalton has all these contacts in the industry, but you have to admit a person with all these connections(U.S. Senate, Blue Shield, PPSI, Etc) we need a real website and should NOT be trading in the sub-penny (.001) range. Univec competitors trade on the NYSE/Nas. This guy could practically run for president with all his accomplishments. UNVC needs to get to real levels to reflect the real value of this companies worth and it wouldn't hurt if Dalton updated shareholders from time to time! I believe good things are in store for us here, just some patience.
I agree. I think the main questions now are how many hospitals are going to be buying Univec Inc products and knowing they will be reimbursed by Medicare?
I have many friends that are pharma-reps that push all kinds of products, trials, etc out to doctors/hospitals/etc. Is that where we are now being Univec Inc received the FDA Labeler code? I would assume with all Dr. David Dalton's contacts in the field he most likely just needs to make some calls to get the products out to the right people and make it happen. In addition, how good are the products is there a demand for them or do they work just as good as any other medical product. Any thoughts?
Good chart Mods should put that up in the box.
someone has been picking up a nice chunk of shares in this range the last few days, something big must be brewing.
.0012s printing :)
We should be back in the .002 range no reason to be in this level, way undervalued here.
We have buyers up in here, someone adding on the sneak.
Ask: .0012 any word on news?
Share Structure
Market Value1 - $286,817 - a/o Sep 02, 2011
Shares Outstanding - 286,816,901 - a/o Jun 30, 2011
Float - 166,867,522 - a/o Jul 18, 2011
Authorized Shares - 500,000,000 - a/o Jun 30, 2011
Par Value - 0.01
For all those newbsters who were sweating bullets in the .0007 - .0008 range give yourself a pat on the back if your still here. I said many many times don't feed the bears. Patience is key. These MMs play their little games throughout the day.
We are at rock bottom levels. This company has an excellent share structure. Something REAL is happening as we obviously seen from the FDA filings. I don't want to be the one kicking myself when this is in the pennies. Let's get updates Dalton!
pip, wasn't me. was trying to get 8s never got them.
Sure hope our ceo has something good for us
The O/S is to thin don't think that person will ever get all that filled at .0009, this moves quick.
Pretty pretty sweet :) looks like this show is about to get started.
someone is accumulating shares on the sneak, something big must be brewing.
ha exactly, i am sitting on the bid from .0008 all the way down trying to get filled anywhere i can to scoop up some cheapies. Seems we have a pretty solid support here in the .0008 to .001 not sure if it will happen.
can't let them intimidate you, i been here since Nov 2010 and see the tactics they pull when we get down to these levels to get the newbie "emotional ones" to hit the sell trigger. Don't feed the Bears! Patience is key.
i see you shorties 5,000@.0008 $4.00 now that's funny.
what's your time frame on another run?
Thoughts on UNVC, due for another run?
Interested to know why the last PR regarding FDA approval is not showing on any major news wires (yahoo finance, bloomberg, forbes, etc). It makes sense now why we are channeling in the .0008 - .001 range. This last PR didn't even get out there, it only hit a few smaller news wires that penny players nibble at. If this hit the other major wires mentioned above no doubt about it this would be over .01+ in my opinion. Has anyone mentioned this to the CEO?
gotta love the silence before the storm, don't feed the bears :)
(UNVC) Univec Inc. announces FDA approval of labeler code.
Aug 12, 2011
OTC Disclosure & News Service
Owings Mills, MD -
univec inc.
The Specialty Pharmaceutical Company
FOR IMMEDIATE
RELEASE
Contact:
Investor relations: David Dalton, President
E-mail univec@univecinc.com
UNIVEC announces FDA approval of Labeler Code.
Owings Mills, Maryland —August 8, 2011– Univec, Inc. (UNVC) a specialty pharmaceutical company, announces it has been issued a FDA labeler code. This is the prefix for each National Drug Code (NDC) on products that is manufactured and distributed by Univec for the company’s Specialty Pharmaceuticals. The National Drug Code is a unique identifier assigned by the FDA to identify the manufacturer of a prescription drug product intended for human use. The NDC number is also used in the electronic claim processing for payment by third party entities and e-prescribing for physicians.
David L. Dalton, President and CEO of Univec stated. “ We are delighted to make progress in our new business model. The National Drug Codes are very important not only from the standpoint of the FDA, but it also allows payment from Medicare, Medicaid, Insurance companies and other third party payment systems. This is another milestone reached in placement of a solid foundation to build and grow the company. We thank our associates, shareholders and investors for the support and confidence they have shown the company. ”
About Univec
Univec, Inc. A minority business enterprise (MBE) is a Specialty Pharmaceutical Company that manufactures and distributes high cost Specialty Pharmaceuticals. Specialty Pharmaceuticals are high cost products that are not usually dispensed in retail pharmacies but require special handling and a complex pharmaceutical regime. The company is focused on diseases such as Sickle Cell Anemia, Cancer, HIV/Aids, Hepatitis C., Multiple Sclerosis, Hemophilia and Drug addiction.
PPSI (PHYSICIAN AND PHARMACEUTICAL SERVICES, INC.) a subsidiary of Univec promotes and pays for pharmaceutical products though its network of pharmacies. PPSI eliminates the need for the pharmaceutical companies to distribute actual drug samples to physicians reducing potential liability for the physician while maintaining clinical oversight and drug interaction checks for the patient. The company through it’s “StarterScript” allows in lieu of a physician sample, a voucher or a co-payment card to be provide to the patient for a trial supply of medication redeemed in any of the nearly 55,000 retail pharmacies utilizing the PPSI real-time processing system.
Forward Looking Statements
This document may contain forward-looking statements based on current expectations that could be affected by the risks and uncertainties involved in Univec’s business. These risks and uncertainties include, but are not limited to, the risks described from time to time in Univec’s reports to the General Public and reporting agencies. Subsequent written or oral statements attributable to Univec or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this document and those in Univec’s reports filed
-End-
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
(UNVC) Univec Inc. announces FDA approval of labeler code.
Aug 12, 2011
OTC Disclosure & News Service
Owings Mills, MD -
univec inc.
The Specialty Pharmaceutical Company
FOR IMMEDIATE
RELEASE
Contact:
Investor relations: David Dalton, President
E-mail univec@univecinc.com
UNIVEC announces FDA approval of Labeler Code.
Owings Mills, Maryland —August 8, 2011– Univec, Inc. (UNVC) a specialty pharmaceutical company, announces it has been issued a FDA labeler code. This is the prefix for each National Drug Code (NDC) on products that is manufactured and distributed by Univec for the company’s Specialty Pharmaceuticals. The National Drug Code is a unique identifier assigned by the FDA to identify the manufacturer of a prescription drug product intended for human use. The NDC number is also used in the electronic claim processing for payment by third party entities and e-prescribing for physicians.
David L. Dalton, President and CEO of Univec stated. “ We are delighted to make progress in our new business model. The National Drug Codes are very important not only from the standpoint of the FDA, but it also allows payment from Medicare, Medicaid, Insurance companies and other third party payment systems. This is another milestone reached in placement of a solid foundation to build and grow the company. We thank our associates, shareholders and investors for the support and confidence they have shown the company. ”
About Univec
Univec, Inc. A minority business enterprise (MBE) is a Specialty Pharmaceutical Company that manufactures and distributes high cost Specialty Pharmaceuticals. Specialty Pharmaceuticals are high cost products that are not usually dispensed in retail pharmacies but require special handling and a complex pharmaceutical regime. The company is focused on diseases such as Sickle Cell Anemia, Cancer, HIV/Aids, Hepatitis C., Multiple Sclerosis, Hemophilia and Drug addiction.
PPSI (PHYSICIAN AND PHARMACEUTICAL SERVICES, INC.) a subsidiary of Univec promotes and pays for pharmaceutical products though its network of pharmacies. PPSI eliminates the need for the pharmaceutical companies to distribute actual drug samples to physicians reducing potential liability for the physician while maintaining clinical oversight and drug interaction checks for the patient. The company through it’s “StarterScript” allows in lieu of a physician sample, a voucher or a co-payment card to be provide to the patient for a trial supply of medication redeemed in any of the nearly 55,000 retail pharmacies utilizing the PPSI real-time processing system.
Forward Looking Statements
This document may contain forward-looking statements based on current expectations that could be affected by the risks and uncertainties involved in Univec’s business. These risks and uncertainties include, but are not limited to, the risks described from time to time in Univec’s reports to the General Public and reporting agencies. Subsequent written or oral statements attributable to Univec or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this document and those in Univec’s reports filed
-End-
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
you were lucky to get some 7s i couldn't even get 8s waited a few days nothing. i am averaged in at all different prices since November 2010. I think patience will be paying off shortly :)
Good post Lowman agree. Getting some buying action coming in here for a Friday perhaps a PR is brewing for early next week!
MMs trying hard to keep this under .001. To much buying pressure building up.
Univec Inc. has formed affiliate agreements with major pharmaceutical firms for production and distribution efficiency.
http://univecinc.com/Home.html
What major pharmaceutical firms are they talking about?
We have just touched the surface of what is going on here.
Big announcements and Big news should be coming soon.
I like how the MMs try to keep this down
$0.0009 --- 5,000 --- OTO --- 09:38:44
That's $4.50 to funny. Don't fall for their tricks!
Don't feed the bears! long and strong UNVC.
i think we will see some healthy buying coming in tomorrow as you wouldn't want to be left on the sidelines if we get hit with an explosive PR after the holiday weekend. Cheers!
Yup, and we are in at the bottom floor here. This has been in the works for a long time, FDA approvals on medical devices don't happen overnight. I believe all the stars have just about aligned here and it will pay off soon. I could have sold on a few runs now, sure would kick myself when the real run doesn't stop and keeps going. Long and strong UNVC.
I feel this is a big pharma company in the making here with all these patents over the years and recent FDA approval on the Labeler code this has been a silent sleeper that is just waking up. With our CEO Dr. David Dalton who has all the right connections i feel like this is the ground floor of something major, just a little patience.
UNVC starting to uptick i am in. You speak to Dalton i think it's take off time!!
Ask: .001$ back up :) up we go
are you loading up on UNVC today? speak to Dalton? sounds like good things about to start brewing.
are you loading up on UNVC today? speak to Dalton?